Nature rejects Krebs's paper, 1937

What would be the perfect revenge for a scientist whose paper is turned away from Nature? A Nobel Prize, of course.

Written byBrendan Borrell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

What would be the perfect revenge for a scientist whose paper is turned away from Nature? A Nobel Prize, of course. Such was the case for Hans Krebs, the biochemist who nabbed the award in 1953 for discovering the citric acid cycle, or “Krebs cycle”—the cellular pathway that converts carbohydrates, fats, and proteins into energy.

Krebs, a German-born Jew trained in medicine and chemistry, was forced out of his position at the University of Freiburg as the Nazis rose to power in the early 1930s. Fleeing the country for England, he joined the faculty of the University of Sheffield in 1935, where he achieved his groundbreaking discoveries.

In March 1937, Krebs and a colleague minced the breast of a freshly killed pigeon in their lab, suspended it in solution, and observed its metabolic rate decline over the next half hour. By adding a salt of citric acid, however, they were ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform